References
- Baranowska, B., et al., 2019. Copeptin – a new diagnostic and prognostic biomarker in neurological and cardiovascular diseases. Neuro endocrinology letters, 40 (5), 207–214.
- Barwari, T., et al., 2016. MicroRNAs in cardiovascular disease. Journal of the American college of cardiology, 68 (23), 2577–2584.
- Benjamin, E.J., et al., 2018. Heart disease and stroke statistics-2018 update: a report from the american heart association. Circulation, 137 (12), e67–e492.
- Benjamin, E.J., et al., 2019. Heart Disease and Stroke Statistics-2019 Update: a report from the american heart association. Circulation, 139 (10), e56–e528.
- Bi, S., et al., 2015. Correlation between serum exosome derived miR-208a and acute coronary syndrome. International journal of clinical and experimental medicine, 8 (3), 4275.
- Gensini, G.G., 1983. A more meaningful scoring system for determining the severity of coronary heart disease. The American journal of cardiology, 51 (3), 606.
- Grüntzig, A.R., et al., 1979. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. The new England journal of medicine, 301 (2), 61–68.
- Hammond, S.M., 2015. An overview of microRNAs. Advanced drug delivery reviews, 87, 3–14.
- Hessvik, N.P., et al., 2018. Current knowledge on exosome biogenesis and release. Cellular and molecular life sciences: CMLS, 75 (2), 193–208.
- Jiao, X., et al., 2017. Serum and exosomal miR-122 and miR-199a as a biomarker to predict therapeutic efficacy of hepatitis C patients. Journal of medical virology, 89 (9), 1597–1605.
- Kim, K.S., et al., 2020. Copeptin with high-sensitivity troponin at presentation is not inferior to serial troponin measurements for ruling out acute myocardial infarction. Clinical and experimental emergency medicine, 7 (1), 35–42.
- Li, D.-B., et al., 2018. Plasma Exosomal miRNA-122-5p and miR-300-3p as potential markers for transient ischaemic attack in rats. Frontiers in aging neuroscience, 10, 24.
- Li, H., et al., 2019. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease. Bioscience reports, 39 (5), BSR20182016.
- Ling, H., et al., 2020. Serum Exosomal MicroRNA-21, MicroRNA-126, and PTEN are novel biomarkers for diagnosis of acute coronary syndrome. Frontiers in physiology, 11, 654.
- Möckel, M., et al., 2014. Copeptin-marker of acute myocardial infarction. Current atherosclerosis reports, 16 (7), 421.
- Neeland, I.J., et al., 2012. Coronary angiographic scoring systems: an evaluation of their equivalence and validity. American heart journal, 164 (4), 547–552.
- Singh, S., et al., 2020. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability. Open heart, 7 (1), e001223.
- Sinning, C., et al., 2013. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clinical Research in Cardiology, 102 (7), 495–503.
- Smith, J.N., et al., 2015. Diagnosis and management of acute coronary syndrome: an evidence-based update. Journal of the American board of family medicine: JABFM, 28 (2), 283–293.
- Su, J., et al., 2020. Exosomal miRNAs as potential biomarkers for acute myocardial infarction. IUBMB life, 72 (3), 384–400.
- Yao, X.L., et al., 2015. Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction. International journal of clinical and experimental pathology, 8 (12), 16014–16019.
- Zhang, J., et al., 2015. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics, proteomics & bioinformatics, 13 (1), 17–24.
- Zhang, Z.Q., et al., 2019. Abnormal circadian rhythms are associated with plaque instability in acute coronary syndrome patients. International Journal of Clinical and Experimental Pathology, 12 (10), 3761–3771.
- Zhu, G.-F., et al., 2014. microRNA-155 is inversely associated with severity of coronary stenotic lesions calculated by the Gensini score. Coronary artery disease, 25 (4), 304–310.